Compare MLAB & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLAB | KIO |
|---|---|---|
| Founded | 1982 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.8M | 470.1M |
| IPO Year | 1995 | 2011 |
| Metric | MLAB | KIO |
|---|---|---|
| Price | $87.80 | $11.37 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $94.00 | N/A |
| AVG Volume (30 Days) | 79.1K | ★ 258.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | ★ 99.24 | N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | $48.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $59.63 | $10.69 |
| 52 Week High | $142.19 | $12.83 |
| Indicator | MLAB | KIO |
|---|---|---|
| Relative Strength Index (RSI) | 45.39 | 31.53 |
| Support Level | $85.91 | N/A |
| Resistance Level | $89.69 | $12.15 |
| Average True Range (ATR) | 4.45 | 0.09 |
| MACD | -0.69 | -0.02 |
| Stochastic Oscillator | 13.35 | 25.32 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
KKR Income Opportunities Fund operates as a closed-end registered management investment company. The Fund's main objective is to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in a portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.